Pharmagen Financial Statements From 2010 to 2025

Pharmagen financial statements provide useful quarterly and yearly information to potential Pharmagen investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Pharmagen financial statements helps investors assess Pharmagen's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Pharmagen's valuation are summarized below:
Gross Profit
2.7 M
Profit Margin
(1.33)
Market Capitalization
362 K
Enterprise Value Revenue
1.3452
Revenue
4.4 M
We have found fourty-six available trending fundamental ratios for Pharmagen, which can be analyzed and compared to other ratios and to its competitors. All investors should make sure to check out all of Pharmagen recent market performance against the performance between 2010 and 2025 to make sure the company can sustain itself down the road.

Pharmagen Total Revenue

5.81 Million

Check Pharmagen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pharmagen's main balance sheet or income statement drivers, such as Discontinued Operations of 0.0, Interest Expense of 0.0 or Selling General Administrative of 6.3 M, as well as many indicators such as Price To Sales Ratio of 0.25, Dividend Yield of 0.0 or Days Sales Outstanding of 22.3 K. Pharmagen financial statements analysis is a perfect complement when working with Pharmagen Valuation or Volatility modules.
  
Check out the analysis of Pharmagen Correlation against competitors.
For more information on how to buy Pharmagen Stock please use our How to Invest in Pharmagen guide.

Pharmagen Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets1.3 M1.5 M1.3 M
Pretty Stable
Total Current Liabilities9.8 M9.3 MM
Slightly volatile
Accounts Payable1.7 M1.6 M1.2 M
Slightly volatile
Cash163.4 K259.9 K204.8 K
Slightly volatile
Net Receivables346.6 K423 K356.8 K
Pretty Stable
Inventory96.9 K157.5 K123.5 K
Slightly volatile
Total Liabilities10.7 M10.2 M7.8 M
Slightly volatile
Short and Long Term Debt2.6 M2.5 M1.8 M
Slightly volatile
Total Current Assets783.1 KM839.7 K
Pretty Stable
Common Stock279.5 K499.6 K383.7 K
Slightly volatile

Pharmagen Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative6.3 MM4.6 M
Slightly volatile
Total Revenue5.8 M5.5 M4.3 M
Slightly volatile
Gross Profit3.7 M3.5 M2.7 M
Slightly volatile
Cost Of Revenue1.4 MM1.6 M
Slightly volatile
Total Operating Expenses8.4 MM6.3 M
Slightly volatile

Pharmagen Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Sale Purchase Of Stock30.1 K31.7 K37.2 K
Slightly volatile
Depreciation120 K114.2 K88.4 K
Slightly volatile
Capital Expenditures72.7 K65.2 K60.6 K
Very volatile
Change To Liabilities1.1 M1.1 M833.6 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.250.280.305
Slightly volatile
Days Sales Outstanding22.3 K25.1 K27.4 K
Slightly volatile
Stock Based Compensation To Revenue0.020.02250.0246
Slightly volatile
Capex To Depreciation0.460.510.56
Slightly volatile
EV To Sales0.981.11.195
Slightly volatile
ROIC0.630.710.7716
Slightly volatile
Inventory Turnover10.3311.6212.6654
Slightly volatile
Days Of Inventory On Hand22.6225.4527.749
Slightly volatile
Payables Turnover0.0010.00120.0013
Slightly volatile
Sales General And Administrative To Revenue0.530.60.6501
Slightly volatile
Capex To Revenue0.00940.01060.0116
Slightly volatile
Cash Per Share5.0E-45.0E-46.0E-4
Slightly volatile
Days Payables Outstanding227.8 K256.3 K279.5 K
Slightly volatile
Income Quality0.0960.10.1132
Slightly volatile
ROE0.680.770.8354
Slightly volatile
Intangibles To Total Assets0.01250.0140.0153
Slightly volatile
Current Ratio0.0880.09770.1066
Slightly volatile
Receivables Turnover0.01050.01180.0128
Slightly volatile
Capex Per Share1.0E-41.0E-41.0E-4
Slightly volatile
Graham Net Net0.560.630.6843
Slightly volatile
Revenue Per Share0.010.01130.0123
Slightly volatile
Interest Debt Per Share6.287.077.707
Slightly volatile
Debt To Assets2.863.223.5109
Slightly volatile
Operating Cycle22.3 K25.1 K27.4 K
Slightly volatile
Days Of Payables Outstanding227.8 K256.3 K279.5 K
Slightly volatile
Ebt Per Ebit2.222.52.7269
Slightly volatile
Long Term Debt To Capitalization0.820.910.9966
Slightly volatile
Return On Capital Employed0.260.290.3115
Slightly volatile
Quick Ratio0.07340.08250.0899
Slightly volatile
Net Income Per E B T0.860.971.056
Slightly volatile
Cash Ratio0.02230.02510.0274
Slightly volatile
Days Of Inventory Outstanding22.6225.4527.749
Slightly volatile
Days Of Sales Outstanding22.3 K25.1 K27.4 K
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.860.971.0611
Slightly volatile
Fixed Asset Turnover10.0611.3112.3309
Slightly volatile
Debt Ratio2.863.223.5109
Slightly volatile
Price Sales Ratio0.250.280.305
Slightly volatile
Asset Turnover3.03.383.683
Slightly volatile
Gross Profit Margin0.50.570.6205
Slightly volatile
Return On Equity0.680.770.8354
Slightly volatile

Pharmagen Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap1.2 K1.3 K1.5 K
Slightly volatile
Enterprise Value4.7 K5.3 K5.7 K
Slightly volatile

About Pharmagen Financial Statements

Pharmagen investors use historical fundamental indicators, such as Pharmagen's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Pharmagen. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Revenue5.5 M5.8 M
Cost Of RevenueM1.4 M
Stock Based Compensation To Revenue 0.02  0.02 
Sales General And Administrative To Revenue 0.60  0.53 
Capex To Revenue 0.01  0.01 
Revenue Per Share 0.01  0.01 
Ebit Per Revenue(0.40)(0.42)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Pharmagen Stock Analysis

When running Pharmagen's price analysis, check to measure Pharmagen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmagen is operating at the current time. Most of Pharmagen's value examination focuses on studying past and present price action to predict the probability of Pharmagen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmagen's price. Additionally, you may evaluate how the addition of Pharmagen to your portfolios can decrease your overall portfolio volatility.